2025-11-16 - Analysis Report
Okay, here's an analysis of Honeywell International Inc (HON) based on the data you provided. The report is structured to first present the key numbers, followed by analysis and insights.

**Report: Honeywell International Inc (HON) Analysis**

**0. Overview**

*   **Ticker:** HON
*   **Company Description:** Honeywell International Inc. is a diversified technology and manufacturing company.

**1. Performance vs. S&P 500 (VOO)**

*   **HON Cumulative Return:** 10.12%
*   **VOO Cumulative Return:** 98.45%
*   **Absolute Performance Gap:** -90.8 (HON is significantly underperforming VOO)
*   **Relative Performance Gap:** 2.5 (HON's underperformance is near the bottom of its historical range compared to VOO)

**Analysis:**

HON has significantly underperformed the S&P 500. While the relative performance gap suggests it's near the bottom of its historical underperformance, the absolute difference is substantial.

**Alpha, Beta Analysis**

| Year       | CAGR  | MDD   | Alpha  | Beta | Cap(B) |
|------------|-------|-------|--------|------|--------|
| 2015-2017  | 33.0% | 67.3% | 5.0%  | -0.0 | 93.7   |
| 2016-2018  | 15.0% | 71.0% | 0.0%  | 0.0  | 84.2   |
| 2017-2019  | 29.0% | 71.1% | 6.0%  | 0.9  | 112.8  |
| 2018-2020  | 6.0%  | 79.4% | -18.0% | 1.0  | 135.6  |
| 2019-2021  | 19.0% | 79.4% | -28.0% | 1.2  | 132.9  |
| 2020-2022  | 9.0%  | 79.4% | 10.0%  | 1.3  | 136.6  |
| 2021-2023  | -9.0% | 77.9% | -10.0% | 1.2  | 133.7  |
| 2022-2024  | -2.0% | 79.7% | -22.0% | 1.2  | 144.0  |
| 2023-2025  | -21.0% | 79.7% | -84.0% | 2.1  | 126.9  |

**Analysis:**

*   **CAGR:** Fluctuating, with recent years showing negative growth.
*   **MDD:** Consistently high Maximum Drawdown indicates high volatility.
*   **Alpha:** Recent years show significant negative alpha, implying underperformance relative to its risk.
*   **Beta:** Beta is around 1 or higher, suggesting HON's price is as volatile or more volatile than the market.
*   **Cap(B):** Market capitalization has generally increased but dipped in the most recent period.

**2. Recent Stock Price Movements**

*   **Current Price:** 199.04
*   **Previous Close:** 198.68
*   **Change:** 0.18
*   **5-day Moving Average:** 199.396
*   **20-day Moving Average:** 199.1395
*   **60-day Moving Average:** 199.2169

**Analysis:**

The stock price is trading slightly above its previous close. The moving averages are very close to each other, indicating a lack of a strong trend. The small change suggests no significant immediate market reaction.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 41.79 (Neutral, not overbought or oversold)
*   **PPO:** 0.1 (Neutral)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.80) Dividend_1.19
*   **Recent Relative Divergence Change (20-day):** 0.5 (+) (Short-term increase in relative strength)
*   **Expected Return:** -1123.6% (Significantly Negative)

**Analysis:**

*   The MRI suggests a medium investment recommendation, indicating moderate risk.
*   The RSI and PPO are neutral, suggesting a lack of strong momentum.
*   The Hybrid signal suggests a Buy recommendation with a focus on safety.
*   The recent increase in relative divergence suggests some short-term positive momentum.
*   The *extremely* negative expected return is alarming and requires further investigation. It suggests very poor long-term prospects based on the model used to calculate it.

**4. Recent News & Significant Events**

*   **Price Target Cuts:** Argus and Wells Fargo have lowered their price targets for HON.
*   **Analyst Report:** Argus Research issued an analyst report on HON.
*   **Market Commentary:** HON is mentioned in articles discussing industrial stocks and overall market selloff.

**Analysis:**

The news is generally negative, with analysts reducing price targets. This suggests concerns about HON's near-term performance.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~1.92)
*   **Target Price (avg/high/low):** 243.49 / 271.00 / 210.00

**Analysis:**

Despite recent price target cuts, the overall analyst consensus is still a "Buy" with an average target price significantly above the current price. This indicates that analysts, on average, believe the stock is undervalued.

**5. Recent Earnings Analysis**

| 날짜         | EPS  | 매출        |
|--------------|------|-------------|
| 2025-10-23 | 2.87 | 10.41 B$   |
| 2025-07-24 | 2.46 | 10.35 B$   |
| 2025-04-29 | 2.24 | 9.82 B$    |
| 2024-10-24 | 2.17 | 9.73 B$    |
| 2025-10-23 | 2.17 | 9.73 B$    |

**Analysis:**

*   Both EPS and Revenue have generally increased over the recent quarters, which is a positive sign. The most recent EPS of 2.87 is a high point in the provided data.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30 | $10.41B  | 34.08%        |
| 2025-06-30 | $10.35B  | 38.86%        |
| 2025-03-31 | $9.82B   | 38.54%        |
| 2024-12-31 | $10.09B  | 36.38%        |
| 2024-09-30 | $9.73B   | 38.54%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-09-30 | $16.78B  | 10.87%   |
| 2025-06-30 | $16.09B  | 9.75%    |
| 2025-03-31 | $17.46B  | 8.30%    |
| 2024-12-31 | $18.62B  | 6.90%    |
| 2024-09-30 | $17.41B  | 8.12%    |

**Analysis:**

*   **Revenue:** Increasing trend, indicating healthy sales.
*   **Profit Margin:** Fluctuating but generally high, indicating good cost control.
*   **Equity:** Fluctuating, with a recent decline.
*   **ROE:** Increasing trend, indicating improving profitability relative to equity.

**7. Overall Summary & Conclusion**

Honeywell (HON) presents a mixed picture:

*   **Negative Aspects:**
    *   Significant underperformance compared to the S&P 500.
    *   Recent analyst price target cuts and negative news headlines.
    *   Extremely negative "expected return" (This requires urgent validation/investigation of the calculation).
    *   High MDD and negative Alpha indicating high volatility and underperformance relative to risk.
*   **Positive Aspects:**
    *   Recent improvements in revenue, EPS, and ROE.
    *   Overall analyst consensus remains a "Buy" with a significant upside target price.
    *   Medium Market Risk Indicator suggests moderate risk.
    *   Hybrid Signal suggests a Buy recommendation.

**Conclusion:**

The contradictory signals suggest caution. While the underlying financial performance (revenue, earnings) shows positive trends and analysts see long-term upside, the underperformance against the S&P 500, negative news sentiment, price target cuts and the extremely negative expected return are concerning.
The negative expected return calculation requires further validation. If it's accurate, it signals significant potential downside risk.
A neutral stance is warranted until further clarification of the expected return and a more sustained positive trend emerges. I recommend investigating the source and methodology used to calculate the 'Expected Return' to ensure its accuracy.
